New Understanding of Fanconi Anemia Signaling Network upon Studying FANCD2 | Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.7, No. 2)Publication Date: 2020-01-29
Authors : Kanani Hokutan; Jin-Hee Kim; Sudong Zhan; Jun Zhang; Peiwen Fei;
Page : 124-126
Keywords : Biomedical Science and Research Journals; Biomedical Open Access Journals; Biomedical Research Journals; Open Access Journals of Nanomedicine; Journal of Nanomedicine; Nanomedicine Journal of Health Science;
Abstract
The Fanconi Anemia (FA) pathway is activated upon replication stress and DNA damage. With the accumulated studies, this pathway has emerged as a fundamental signaling network to defend genome stability. The Fanconi Anemia complementation group D2 protein (FANCD2) sits at the center of the pathway, orchestrating many players to prevent our genome from going awry, leading to diseases including cancer. Here, we highlight recent advances in our understanding of FA signaling, emphasizing on a rarely known form of FANCD2, FANCD2-V2.
Other Latest Articles
- The Right Little Fingerprint of Rev. Dr. Martin Luther King, Jr. | Biomedgrid
- Heavy Metals in Barnacles Balanus Sp.: From Biomonitoring to Coastal Management | Biomedgrid
- Transient AV Complete Heart Block: A Rare Complication Following Regadenoson Injection | Biomedgrid
- The Mediterranean Diet: Plant Lectins as Essential Components | Biomedgrid
- Bio Polymerization as One of The Stimulation Cause of The Cancer Cell Multiplication | Biomedgrid
Last modified: 2022-04-29 15:21:37